Pentapharm Ltd. is a Swiss-based developer and manufacturer of specialty active ingredients for the personal care industry, with a strong focus on peptide technologies used in skin care. The business forms part of dsm-firmenich’s Perfumery & Beauty segment, supplying ingredients that enable performance claims in areas such as anti-aging, firming, smoothing, and skin barrier support.
Pentapharm’s activities span research and development, scale-up, quality-controlled production, and technical support for formulators. Its portfolio of cosmetic actives and functional ingredients is used by global beauty and dermocosmetic brands, and is backed by regulatory and safety documentation suited to international markets. Through dsm-firmenich’s network, Pentapharm reaches customers worldwide across premium and mass-market applications.
None yet. When a new project in the record names Pentapharm Ltd. as owner, partner or investor, it shows here.
Financials reclassified post-ANH divestment; new reporting structure and KPI adjustments outlined; further details to follow in 2026.
